Sterling Biotech receives NBWs in Rs 8,100-crore bank loan fraud case

A Delhi court Saturday issued open-ended non-bailable warrants (NBWs) against four directors of a Gujarat pharma firm in a Rs 8,100-crore money laundering probe case.

Additional Sessions Judge Satish Kumar Arora allowed the Enforcement Directorate’s plea seeking issuance of NBW against Sterling Biotech Ltd (SBL) directors Nitin Jayantilal Sandesara, Chetankumar Jayantilal Sandesara, Dipti Chetan Sandesara and Hiteshkumar Narendrabhai Patel.

The ED has registered the alleged bank fraud case against the firm SBL under sections of the Prevention of Money Laundering Act (PMLA).

The accused are also being probed by the ED for allegedly bribing senior income tax department officials as part of an earlier criminal complaint.

  • Related Posts

    • Pharma
    • April 30, 2025
    • 15 views
    Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

    New Delhi:  A recent study found that a daily exposure to phthalates, that is commonly used in making household plastic items, is linked to 3.5 lakh, or 13 per cent,…

    • Pharma
    • April 29, 2025
    • 101 views
    Cargologic receives CEIV Pharma re-certification

    The pharmaceutical industry relies heavily on airfreight for its speed, efficiency and reliability in transporting time-sensitive and temperature-controlled shipments – ensuring product integrity throughout the supply chain. While air transport…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

    Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

    Cargologic receives CEIV Pharma re-certification

    Cargologic receives CEIV Pharma re-certification

    Dr. Reddy’s to introduce Sanofi’s novel RSV drug in India

    Dr. Reddy’s to introduce Sanofi’s novel RSV drug in India

    Japan’s Takeda to launch dengue vaccine in India with Biological E next year

    Japan’s Takeda to launch dengue vaccine in India with Biological E next year